0 Commentaires
0 Parts
1112 Vue
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
- Blogs
- Offres
- Emplois
- Connectez-vous pour aimer, partager et commenter!
- Biologics Contract Development And Manufacturing Organization Market Analysis and Growth InsightsThe global biologics contract development and manufacturing organization market size was estimated at USD 19.22 billion in 2024 and is projected to reach USD 42.32 billion by 2033, growing at a CAGR of 9.21% from 2025 to 2033. This steady expansion is primarily attributed to the rising prevalence of chronic and rare diseases worldwide, which has significantly increased the demand for...0 Commentaires 0 Parts 1590 Vue
- Cancer Biologics Market Size to Hit USD 219.58 Billion by 2033 Driven by Rising Cancer Treatment InnovationsCancer Biologics Market Snapshot: Straits Research has recently added a new report to its vast depository titled Cancer Biologics Market. The report studies vital factors about the Cancer Biologics Market that are essential to be understood by existing as well as new market players. The report highlights the essential elements such as market share, profitability,...0 Commentaires 0 Parts 1112 Vue
- Cancer Biologics Market to Reach USD 219.58 Billion by 2033, Growing at a CAGR of 6.7%The global Cancer Biologics Market is witnessing significant growth, driven by the increasing prevalence of cancer, advancements in biotechnology, and the rising adoption of targeted therapies. Cancer biologics, including monoclonal antibodies, vaccines, and cell-based therapies, are transforming oncology treatment by offering improved efficacy and reduced side effects compared to...0 Commentaires 0 Parts 377 Vue
- CDMO Market Trends: AI Integration in Bioprocess Development and ManufacturingThe evolution of biologics is reshaping how modern medicines are developed, produced, and delivered, and at the center of this transformation lies the growing importance of the large molecule CDMO ecosystem. As pharmaceutical companies increasingly focus on innovation while outsourcing complex manufacturing processes, the role of a reliable biologics CDMO has become more strategic than ever....0 Commentaires 0 Parts 893 Vue
- cGMP Process Development Market to Reach USD 6.06 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global cGMP Process Development market was valued at USD 3.75 billion in 2025 and is projected to reach USD 6.06 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2032. cGMP process development represents the critical discipline of systematically designing,...0 Commentaires 0 Parts 1000 Vue
- North America GI Drugs Market Outlook: Key Players, Revenue & OpportunitiesThe global gastrointestinal drugs market is witnessing strong growth due to the increasing prevalence of digestive disorders, rising healthcare awareness, expanding biologics development, and growing pharmaceutical innovations. Gastrointestinal drugs are widely used to treat disorders affecting the digestive tract, including irritable bowel syndrome (IBS), ulcerative colitis, Crohn’s...0 Commentaires 0 Parts 245 Vue
- Rare Neurological Disease Treatment Market North America Revenue OutlookThe global rare neurological disease treatment market is witnessing substantial growth due to increasing awareness regarding rare neurological disorders, rising investments in orphan drug development, and rapid advancements in biotechnology and precision medicine. Rare neurological diseases are complex disorders that affect the brain, spinal cord, nerves, and muscles, often leading to severe...0 Commentaires 0 Parts 291 Vue
- Recombinant Human Erythropoietin Injection Market to Reach USD 10.2 Billion by 2032 | CAGR 3.8%According to a newly published market research report by 24LifeSciences, the global recombinant human erythropoietin injection market was valued at USD 7.6 billion in 2024 and is projected to reach USD 10.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.8% during the forecast period 2025–2032. Recombinant human erythropoietin (rhEPO) injection is a...0 Commentaires 0 Parts 862 Vue
- Treatment Advancements and Outlook for Pemphigus Vulgaris MarketThe global Pemphigus Vulgaris Market is witnessing steady growth, driven by increasing prevalence of autoimmune disorders, rising awareness regarding early diagnosis, and advancements in biologic therapies. Growing clinical research activities and improved access to dermatological treatments are further supporting market expansion worldwide. Market Size and Growth The global pemphigus...0 Commentaires 0 Parts 1033 Vue
Plus de résultats
© 2026 Mạng xã hội kotra-hanoi.org.vn
French